Program Overview

Kite and Gilead Sciences Research Scholars Program in Hematologic Malignancies

The program provides financial support to 3 junior faculty researchers for a 2-year period. Each award is funded up to  $130,000 USD (inclusive of any indirect costs), to be paid in annual installments of up to $65,000 USD per year for 2 years payment to be made to researcher’s institution. Funding for the second year is contingent upon submission of a progress report by each junior faculty researcher and approval by the Chair of the Scientific Review Committee which oversees the program. 

Recipients of these competitive awards under the program will be selected by a Committee, comprised of leaders in the field of hematology/oncology (the "Scientific Review Committee" or the "Committee"). The Committee will review complete applications and select research proposals based on their scientific merit, feasibility, and innovation. Announcement of Award Recipients will be made at an awardee acknowledgement session hosted by the Committee and senior representatives from Gilead Sciences.

Applicants must meet the eligibility criteria in order to be considered for an award. Refer to the Eligibility section of this website.

 

 

  • GILEAD and the GILEAD logo are registered
  • trademarks of Gilead Sciences, Inc., or one of its related companies. Kite
  • and the Kite Logo are registered trademarks of Kite, a Gilead company.
  • © 2022 Gilead Sciences, Inc. All rights reserved.